james_kehoe

Takeda appoints new chief financial officer

pharmafile | May 12, 2016 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe 

Takeda Pharmaceuticals has named James Kehoe its new chief financial officer.

He will begin the role on June 15 2016, and be based in Tokyo where he will report directly to the Christophe Weber, president and CEO at Takeda.

Kehoe brings a wealth of experience from the consumer goods sector to the role. Having gained his MSc in Finance from University College Dublin, Kehoe held senior finance roles at companies such as Kraft Foods Group, Mondelez and Gildan Activewear.

Advertisement

Weber comments: “James Kehoe’s passion for transforming large organisations to achieve higher performance will hold him in good stead as he leads the global finance team to further elevate the company’s business performance and help Takeda deliver its growth ambitions.

“We also believe that James’s values are very much aligned with Takeda’s values and that his personal style will work well with the Takeda executive team and the finance leadership team.”

Related Content

Von Willebrand disease – increasing awareness and access to vital care

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

Combination treatments: Takeda’s Implementation Framework and the broader landscape

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …

Takeda presents positive results from trial of chronic kidney disease treatment

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat …

The Gateway to Local Adoption Series

Latest content